ConjuChem

From Wikipedia, the free encyclopedia
  (Redirected from CJC-1295)
Jump to: navigation, search
ConjuChem Biotechnologies Inc.
Public (TSX has Delisted this Stock)
Industry Biotechnology
Headquarters Montreal, Quebec, Canada
Key people
Mark Perrin
Products Drug Affinity Construct (DAC) and Preformed Conjugate-Drug Affinity Construct (PC-DAC)
Number of employees
44[1]
Website www.conjuchem.com

ConjuChem Biotechnologies Inc. is a medical biotechnology company located in Montreal, Canada which is credited with inventing the experimental peptide hormone CJC-1295.

It employs 45 people, 90% of whom are in research and development.

References[edit]

External links[edit]